Lv31
360 积分 2026-02-27 加入
Effectiveness and safety of reduced-dose rivaroxaban for elderly patients with non-valvular atrial fibrillation: A subanalysis of the EXPAND study
6天前
已完结
Meta-Analysis Comparing Apixaban Versus Rivaroxaban for Management of Patients With Nonvalvular Atrial Fibrillation
7天前
已完结
1-Month or 3-Month DAPT in Women and Men at High Bleeding Risk Undergoing PCI
1个月前
已完结
Efficacy and Safety of Shortened Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials
1个月前
已完结
Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction
1个月前
已完结
Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
1个月前
已完结
Effectiveness and Safety of Ticagrelor Monotherapy After Short-Duration Dual Antiplatelet Therapy in PCI Patients: A Systematic Review and Meta-Analysis
1个月前
已完结
P2Y12inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials
1个月前
已完结
Monotherapy with P2Y12-inhibitors after dual antiplatelet therapy: Filling gaps in evidence
1个月前
已关闭
Short Versus One-Year Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: an Updated Meta-Analysis
1个月前
已完结
皖公网安备34019202002308
